Document Detail

Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study.
MedLine Citation:
PMID:  23339805     Owner:  NLM     Status:  In-Data-Review    
Aims: To report the four-month and nine-month angiographic results as well as one-year clinical follow-up from the first-in-man study with the silicon carbide and sirolimus-eluting bioabsorbable polymer (poly-L-lactic acid (PLLA) polymer) -coated cobalt-chromium Orsiro stent. Methods and results: A group of 30 patients with documented myocardial ischaemia related to a single de novo coronary stenosis up to 22 mm in length, in vessels with a 2.5 to 3.5 mm reference diameter, and between >50% and <90% diameter stenosis were enrolled at two sites. The primary endpoint of the study was in-stent late lumen loss at nine months. The secondary endpoints included major adverse cardiac events (MACE) at one year defined as the composite of cardiac death, ischaemia-driven target lesion revascularisation (TLR) and target vessel myocardial infarction (MI). Procedural success was 100%. Angiographic late lumen loss was 0.12±0.19 mm and 0.05±0.22 mm at four and nine months respectively. At one-year clinical follow-up, the composite MACE was 10% with one patient who died from cardiac death and two patients who had ischaemia-driven target lesion revascularisation. There was no report of MI or stent thrombosis. Conclusions: The Orsiro drug-eluting stent demonstrated potency with low rates of in-stent neointimal hyperplasia and cardiovascular events but warrants further evaluation in a larger population cohort with longer follow-up time points.
Martial Hamon; Rodica Niculescu; Dan Deleanu; Maria Dorobantu; Neil J Weissman; Ron Waksman
Related Documents :
24739065 - Reply to "precipitants of heart failure must be fully considered when predicting readmi...
24329305 - Using dominant eigenvalue analysis to predict formation of alternans in the heart.
23002715 - Neovascularized myxoma-causing abnormal blood flow in the left atrium diagnosed by tran...
23621145 - Cardiac contractility modulation in patients with advanced heart failure.
3337975 - Effect of various low-dose concentrations of verapamil cardioplegia on small-amplitude ...
2417855 - Qt interval prolongation in acute myocardial infarction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  8     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  1006-11     Citation Subset:  IM    
Centre Hospitalier Universitaire de Caen, Caen, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Integrating spatial and temporal oxygen data to improve the quantification of in situ petroleum biod...
Next Document:  First-in-man evaluation of the MOMO cobalt-chromium carbon-coated stent.